Department of General Surgery, Peking University First Hospital, Beijing, China.
Cancer Biol Ther. 2011 Nov 15;12(10):896-907. doi: 10.4161/cbt.12.10.17679.
Tissue factor (TF) is a significant risk factor for hepatic metastasis in patients with colorectal cancer (CRC). However, the mechanism by which TF promotes hepatic metastasis in CRC remains elusive. In this study, we first confirmed that TF expression was significantly correlated with lymph node metastasis, hepatic metastasis and TNM staging in clinical CRC samples, and found that TF expression in colon cancer cell lines was correlated with the invasion ability. Next, by employing TF-overexpressing LOVO cell line as a model we demonstrated that lentivirus mediated knockdown of TF suppressed the migration and invasion of LOVO cells in vitro, and hepatic metastasis of colorectal cancer in nude mice orthotopic model. Mechanistically, we found that TF knockdown decreases colony formation ability and induced autophagy and apoptosis of LOVO cells, and this was at least partly mediated by the activation of unfolded protein response/PERK signaling. In conclusion, our data provide new insight into hepatic metastasis of CRC. Agents targeting TF should be developed as adjuvant therapeutics for CRC metastasis.
组织因子(TF)是结直肠癌(CRC)患者肝转移的重要危险因素。然而,TF 促进 CRC 肝转移的机制仍不清楚。在这项研究中,我们首先证实 TF 表达与临床 CRC 样本中的淋巴结转移、肝转移和 TNM 分期显著相关,并发现结肠癌细胞系中 TF 的表达与侵袭能力相关。接下来,我们通过使用 TF 过表达 LOVO 细胞系作为模型,证明慢病毒介导的 TF 敲低抑制了 LOVO 细胞在体外的迁移和侵袭,并抑制了裸鼠原位模型中结直肠癌的肝转移。从机制上讲,我们发现 TF 敲低降低了 LOVO 细胞的集落形成能力,并诱导 LOVO 细胞发生自噬和凋亡,这至少部分是通过未折叠蛋白反应/ PERK 信号的激活介导的。总之,我们的数据为 CRC 的肝转移提供了新的见解。靶向 TF 的药物应作为 CRC 转移的辅助治疗药物进行开发。